Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows.

Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows. The new molecule combines the specificity of a mature flu fighter with the ...

While the risk of contracting and dying from the H5N1 avian flu remains low for humans, researchers continue to hunt for ...

A new vaccine that combines flu and COVID-19 protection in one shot shows promising results, but the U.S. Food and Drug ...

Infectimune® studies funded by and performed by investigators at the National Institute of Allergy and Infectious Diseases (NIAID)’s Center for Influenza Vaccine Research for High-Risk Populations ...

The influenza virus manipulates the body's gene regulation system to accelerate its own spread, according to researchers at ...

It takes several hours for the results of a polymerase chain reaction test, which “detects genetic material from a pathogen ...

The trial, which involved more than 8,000 adults 50 and older, found that antibody levels generated by the new vaccine were about 20% to 40% higher than getting the shots apart, with the exception of ...

Cidara Therapeutics shifted its focus from antifungal treatments to its proprietary Cloudbreak drug Fc conjugate platform.

While the risk of contracting and dying from the H5N1 avian flu remains low for humans, researchers continue to hunt for ...